Noh DY - Search Results

1

Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study.

Son BH, Ahn SH, Kim SW, Kang E, Park SK, Lee MH, Noh WC, Kim LS, Jung Y, Kim KS, Noh DY, Moon BI, Suh YJ, Lee JE, Choi DH, Kim SY, Jung SH, Yom CK, Lee H, Yang JH; KOHBRA Research Group and Korean Breast Cancer Society. Son BH, et al. Among authors: noh wc, noh dy. Breast Cancer Res Treat. 2012 Jun;133(3):1143-52. doi: 10.1007/s10549-012-2001-0. Epub 2012 Mar 2. Breast Cancer Res Treat. 2012. PMID: 22382806 Free PMC article.

2

Epidemiology of breast cancer in Korea: occurrence, high-risk groups, and prevention.

Yoo KY, Kang D, Park SK, Kim SU, Kim SU, Shin A, Yoon H, Ahn SH, Noh DY, Choe KJ. Yoo KY, et al. Among authors: noh dy. J Korean Med Sci. 2002 Feb;17(1):1-6. doi: 10.3346/jkms.2002.17.1.1. J Korean Med Sci. 2002. PMID: 11850580 Free PMC article. Review.

3

Polymorphisms in the estrogen receptor-alpha gene and breast cancer risk.

Kang HJ, Kim SW, Kim HJ, Ahn SJ, Bae JY, Park SK, Kang D, Hirvonen A, Choe KJ, Noh DY. Kang HJ, et al. Among authors: noh dy. Cancer Lett. 2002 Apr 25;178(2):175-80. doi: 10.1016/s0304-3835(01)00861-8. Cancer Lett. 2002. PMID: 11867202

4

Identification of angiogenesis in primary breast carcinoma according to the image analysis.

Kim SW, Park SS, Ahn SJ, Chung KW, Moon WK, Im JG, Yeo JS, Chung JK, Noh DY. Kim SW, et al. Among authors: noh dy. Breast Cancer Res Treat. 2002 Jul;74(2):121-9. doi: 10.1023/a:1016150213253. Breast Cancer Res Treat. 2002. PMID: 12186372 Clinical Trial.

5

Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families.

Kang HC, Kim IJ, Park JH, Kwon HJ, Won YJ, Heo SC, Lee SY, Kim KH, Shin Y, Noh DY, Yang DH, Choe KJ, Lee BH, King SB, Park JG. Kang HC, et al. Among authors: noh dy. Hum Mutat. 2002 Sep;20(3):235. doi: 10.1002/humu.9059. Hum Mutat. 2002. PMID: 12204006

6

Phospholipase C-protein kinase C mediated phospholipase D activation pathway is involved in tamoxifen induced apoptosis.

Ahn SJ, Yoon MS, Hyuk S, Han W, Yoon YD, Han JS, Noh DY. Ahn SJ, et al. Among authors: noh dy. J Cell Biochem. 2003 Jun 1;89(3):520-8. doi: 10.1002/jcb.10532. J Cell Biochem. 2003. PMID: 12761885

7

hOGG1 Ser326Cys polymorphism and breast cancer risk among Asian women.

Choi JY, Hamajima N, Tajima K, Yoo KY, Yoon KS, Park SK, Kim SU, Lee KM, Noh DY, Ahn SH, Choe KJ, Han W, Hirvonen A, Kang D. Choi JY, et al. Among authors: noh dy. Breast Cancer Res Treat. 2003 May;79(1):59-62. doi: 10.1023/a:1023305826726. Breast Cancer Res Treat. 2003. PMID: 12779082 Clinical Trial.

8

N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.

Lee KM, Park SK, Kim SU, Doll MA, Yoo KY, Ahn SH, Noh DY, Hirvonen A, Hein DW, Kang D. Lee KM, et al. Among authors: noh dy. Cancer Lett. 2003 Jul 10;196(2):179-86. doi: 10.1016/s0304-3835(03)00311-2. Cancer Lett. 2003. PMID: 12860276

9

Estrogen receptor alpha gene polymorphisms and breast cancer risk.

Shin A, Kang D, Nishio H, Lee MJ, Park SK, Kim SU, Noh DY, Choe KJ, Ahn SH, Hirvonen A, Kim JH, Yoo KY. Shin A, et al. Among authors: noh dy. Breast Cancer Res Treat. 2003 Jul;80(1):127-31. doi: 10.1023/a:1024439202528. Breast Cancer Res Treat. 2003. PMID: 12889606

10

Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features.

Han W, Kang D, Park IA, Kim SW, Bae JY, Chung KW, Noh DY. Han W, et al. Among authors: noh dy. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):124-30. doi: 10.1158/1078-0432.ccr-0834-3. Clin Cancer Res. 2004. PMID: 14734460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

521 results

Search Page